CLINICAL_TRIALS
trial_result
· 2012-07-25
Clinical Trial Update: A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis [Phase 2]
Summary
Phase II placebo-controlled trial evaluating 28 days of oral AZD9668 in bronchiectasis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Bronchiectasis | Phase 2 | Status: COMPLETED | Results posted: 2012-07-25